Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Download
Faster access than browser!
 

Estrogen receptor and Osteoporosis

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Estrogen receptor and Osteoporosis

Estrogen receptor vs. Osteoporosis

Estrogen receptors (ERs) are a group of proteins found inside cells. Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.

Similarities between Estrogen receptor and Osteoporosis

Estrogen receptor and Osteoporosis have 8 things in common (in Unionpedia): Aromatase inhibitor, Bone, Breast cancer, Calcium, Estrogen, Hypothalamus, Mammary gland, Raloxifene.

Aromatase inhibitor

Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and gynecomastia in men.

Aromatase inhibitor and Estrogen receptor · Aromatase inhibitor and Osteoporosis · See more »

Bone

A bone is a rigid organ that constitutes part of the vertebrate skeleton.

Bone and Estrogen receptor · Bone and Osteoporosis · See more »

Breast cancer

Breast cancer is cancer that develops from breast tissue.

Breast cancer and Estrogen receptor · Breast cancer and Osteoporosis · See more »

Calcium

Calcium is a chemical element with symbol Ca and atomic number 20.

Calcium and Estrogen receptor · Calcium and Osteoporosis · See more »

Estrogen

Estrogen, or oestrogen, is the primary female sex hormone.

Estrogen and Estrogen receptor · Estrogen and Osteoporosis · See more »

Hypothalamus

The hypothalamus(from Greek ὑπό, "under" and θάλαμος, thalamus) is a portion of the brain that contains a number of small nuclei with a variety of functions.

Estrogen receptor and Hypothalamus · Hypothalamus and Osteoporosis · See more »

Mammary gland

A mammary gland is an exocrine gland in mammals that produces milk to feed young offspring.

Estrogen receptor and Mammary gland · Mammary gland and Osteoporosis · See more »

Raloxifene

Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.

Estrogen receptor and Raloxifene · Osteoporosis and Raloxifene · See more »

The list above answers the following questions

Estrogen receptor and Osteoporosis Comparison

Estrogen receptor has 131 relations, while Osteoporosis has 250. As they have in common 8, the Jaccard index is 2.10% = 8 / (131 + 250).

References

This article shows the relationship between Estrogen receptor and Osteoporosis. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »